Overview

• Bayer will close its Frankfurt crop protection site by the end of 2028, impacting 500 jobs, with some activities relocated to other facilities.
• Research and development will be centralized in Monheim am Rhein, while production at Dormagen will be streamlined, resulting in 200 job cuts.
• The restructuring aims to counter low-cost competition from Asian generic manufacturers and focus on innovative, higher-margin products.
• Union and works council leaders have criticized the decision, calling it a turning point in Bayer's history and urging consideration of alternatives.
• This move follows years of financial challenges tied to the Monsanto acquisition, including legal liabilities and declining profits in the agribusiness sector.